Marco Egbring

421 total citations
16 papers, 260 citations indexed

About

Marco Egbring is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Emergency Medical Services. According to data from OpenAlex, Marco Egbring has authored 16 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Emergency Medical Services. Recurrent topics in Marco Egbring's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Patient Safety and Medication Errors (4 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). Marco Egbring is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Patient Safety and Medication Errors (4 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). Marco Egbring collaborates with scholars based in Switzerland, Germany and United States. Marco Egbring's co-authors include Gerd A. Kullak‐Ublick, Małgorzata Roos, Andreas Trojan, Mathis Brauchbar, Michael Dietrich, Stefan Russmann, Martin Huber, Alessandro Ceschi, Annika M. Jödicke and Hayk Sargsyan and has published in prestigious journals such as Journal of Medical Internet Research, BMC Health Services Research and European Journal of Clinical Pharmacology.

In The Last Decade

Marco Egbring

16 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Egbring Switzerland	8	51	51	46	41	29	16	260
Norah O. Abanmy Saudi Arabia	11	56 1.1×	30 0.6×	115 2.5×	31 0.8×	36 1.2×	31	417
Marit Waaseth Norway	10	31 0.6×	131 2.6×	33 0.7×	53 1.3×	28 1.0×	29	384
Shelley Wilson United States	9	74 1.5×	96 1.9×	35 0.8×	20 0.5×	40 1.4×	12	390
Molouk Hadjibabaie Iran	11	21 0.4×	89 1.7×	71 1.5×	14 0.3×	38 1.3×	32	414
Maggie Abbassi Egypt	10	24 0.5×	39 0.8×	26 0.6×	19 0.5×	28 1.0×	40	297
Mette Heringa Netherlands	13	41 0.8×	19 0.4×	180 3.9×	52 1.3×	40 1.4×	35	384
Eyayaw Ashete Belachew Ethiopia	9	40 0.8×	45 0.9×	52 1.1×	20 0.5×	25 0.9×	40	344
Olivera Milovanović Serbia	10	118 2.3×	38 0.7×	38 0.8×	20 0.5×	49 1.7×	32	416
Stella Stergiopoulos United States	12	67 1.3×	25 0.5×	16 0.3×	15 0.4×	36 1.2×	28	383
Colleen Conry United States	10	146 2.9×	73 1.4×	24 0.5×	28 0.7×	9 0.3×	22	441

Countries citing papers authored by Marco Egbring

Since Specialization

Citations

This map shows the geographic impact of Marco Egbring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Egbring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Egbring more than expected).

Fields of papers citing papers by Marco Egbring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Egbring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Egbring. The network helps show where Marco Egbring may publish in the future.

Co-authorship network of co-authors of Marco Egbring

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Egbring. A scholar is included among the top collaborators of Marco Egbring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Egbring. Marco Egbring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Trojan, Andreas, et al.. (2021). Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study. JMIR Cancer. 7(1). e26950–e26950. 8 indexed citations

Jödicke, Annika M., et al.. (2020). Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims data. European Journal of Clinical Pharmacology. 76(7). 979–989. 3 indexed citations

Jödicke, Annika M., et al.. (2019). Prediction of health care expenditure increase: how does pharmacotherapy contribute?. BMC Health Services Research. 19(1). 953–953. 14 indexed citations

Jödicke, Annika M., et al.. (2018). Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination. Annals of Pharmacotherapy. 52(10). 983–991. 5 indexed citations

Egbring, Marco, Małgorzata Roos, Michael Dietrich, et al.. (2016). A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial. Journal of Medical Internet Research. 18(9). e238–e238. 73 indexed citations

Dietrich, Michael, Patrick O. Zingg, Marco Egbring, Atul F. Kamath, & Claudio Dora. (2015). Pre-Hospital Medications in Total Hip Arthroplasty: Risk Factors for Poor Outcomes. Hip International. 25(3). 215–220. 7 indexed citations

Egbring, Marco, et al.. (2013). Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates. Digestive Diseases. 31(3-4). 368–373. 82 indexed citations

Egbring, Marco, et al.. (2013). Thrombozytenaggregationshemmer: Was sind die Risiken?. Praxis. 102(20). 1243–1250. 1 indexed citations

Ceschi, Alessandro, et al.. (2012). Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients. European Journal of Clinical Pharmacology. 68(8). 1209–1219. 30 indexed citations

10.

Rosen, Clifford J., et al.. (2012). Drug-related problems and factors influencing acceptance of clinical pharmacologists’ alerts in a large cohort of neurology inpatients. Swiss Medical Weekly. 142(2728). w13615–w13615. 15 indexed citations

11.

Byrne, Kelly, et al.. (2012). Validation of a transparent decision model to rate drug interactions. BMC Pharmacology and Toxicology. 13(1). 7–7. 8 indexed citations

12.

Egbring, Marco, et al.. (2011). Performance of different data sources in identifying adverse drug events in hospitalized patients. European Journal of Clinical Pharmacology. 67(9). 909–918. 4 indexed citations

13.

Egbring, Marco, Gerd A. Kullak‐Ublick, & Stefan Russmann. (2009). Phynx: an open source software solution supporting data management and web‐based patient‐level data review for drug safety studies in the general practice research database and other health care databases. Pharmacoepidemiology and Drug Safety. 19(1). 38–44. 3 indexed citations

14.

Elsner, Christian, et al.. (2003). Open source or commercial products for electronic data capture in clinical trials? a scorecard comparison. 34. 371–373. 5 indexed citations

15.

Egbring, Marco, G Hindricks, Hans Kottkamp, & Christian Elsner. (2002). A real-time monitoring tool for multicentre studies in cardiology. 183–184. 1 indexed citations

16.

Elsner, Christian, Marco Egbring, Hans Kottkamp, & Gerhard Hindricks. (2002). Sharing cardiology cases with students and doctors over the WWW: the Kasus-platform at the Heart Center Leipzig. 185–188. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact